Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 4Withdrawn 2Terminated 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, B-Cell 2Colorectal Neoplasms 2Pancreatic Ductal Adenocarcinoma 1Ototoxicity 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Leukemia, B-Cell 1Hepatoblastoma 1Depression 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Suspended × Depression × Clear all
NCT06213298 2026-02-11

Effect of Kava on Anxiety and Stress in Cancer Survivors

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Suspended
43 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡